To amend section 505 of the Federal Food, Drug, and Cosmetic Act to provide incentives for the development of new combination drugs.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Utah's 3rd congressional district. Republican.
Last Updated: Jan 20, 2015
Length: 5 pages
Jan 20, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on January 20, 2015, in a previous session of Congress, but was not enacted.
Aug 2, 2013
Earlier Version — Introduced
This activity took place on a related bill, H.R. 2985 (113th).
Jan 20, 2015
H.R. 406 (114th) was a bill in the United States Congress.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2018). H.R. 406 — 114th Congress: Combination Drug Development Incentive Act of 2015. Retrieved from https://www.govtrack.us/congress/bills/114/hr406
“H.R. 406 — 114th Congress: Combination Drug Development Incentive Act of 2015.” www.GovTrack.us. 2015. March 24, 2018 <https://www.govtrack.us/congress/bills/114/hr406>
|title=H.R. 406 (114th)
|accessdate=March 24, 2018
|author=114th Congress (2015)
|date=January 20, 2015
|quote=Combination Drug Development Incentive Act of 2015